Evaluation of Inpatient Opioid Prescribing Resulting in Outpatient Opioid Prescriptions for Previously Opioid-Naive Internal Medicine Patients.


Journal

Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 2 10 2020
medline: 3 5 2022
entrez: 1 10 2020
Statut: ppublish

Résumé

Little data exist regarding inpatient opioid prescriptions as a potential contribution to the current opioid crisis. While pain management is essential to inpatient care, the ease of which opioids may be prescribed for all levels of pain may contribute to unnecessary inpatient exposure and new outpatient prescriptions. The aim of this study was to observe patterns of opioid prescribing potentially leading to new opioid prescriptions at hospital discharge for previously opioid-naive patients. This study was a single-center observational study of opioid-naïve internal medicine patients who were prescribed inpatient opioids. Patient charts were reviewed to assess the patterns of inpatient opioid and non-opioid analgesic use, new opioid prescriptions upon discharge and medical record documentation justifying the need for outpatient therapy. Among the 101 patients included in this study, 71 were prescribed IV opioids and 45 were prescribed both IV and oral opioids. Non-opioid analgesics were available for 78 patients. Twenty patients were discharged with a new prescription. The mean duration of outpatient prescriptions was 3.85 +/- 1.85 days with mean morphine milligram equivalents (MME) of 44.25 +/- 22.16. Among patients receiving these outpatient prescriptions, 11 had reference to the therapy in the discharge summary. This observational study describes an opportunity to improve inpatient opioid prescribing practices which may reduce new prescriptions for continued outpatient therapy. Further work should focus on optimizing use of non-opioid analgesia, minimizing use of IV opioids and requiring prescribers to justify the indication for new opioid prescriptions upon hospital discharge.

Sections du résumé

BACKGROUND UNASSIGNED
Little data exist regarding inpatient opioid prescriptions as a potential contribution to the current opioid crisis. While pain management is essential to inpatient care, the ease of which opioids may be prescribed for all levels of pain may contribute to unnecessary inpatient exposure and new outpatient prescriptions. The aim of this study was to observe patterns of opioid prescribing potentially leading to new opioid prescriptions at hospital discharge for previously opioid-naive patients.
METHODS UNASSIGNED
This study was a single-center observational study of opioid-naïve internal medicine patients who were prescribed inpatient opioids. Patient charts were reviewed to assess the patterns of inpatient opioid and non-opioid analgesic use, new opioid prescriptions upon discharge and medical record documentation justifying the need for outpatient therapy.
RESULTS UNASSIGNED
Among the 101 patients included in this study, 71 were prescribed IV opioids and 45 were prescribed both IV and oral opioids. Non-opioid analgesics were available for 78 patients. Twenty patients were discharged with a new prescription. The mean duration of outpatient prescriptions was 3.85 +/- 1.85 days with mean morphine milligram equivalents (MME) of 44.25 +/- 22.16. Among patients receiving these outpatient prescriptions, 11 had reference to the therapy in the discharge summary.
CONCLUSIONS UNASSIGNED
This observational study describes an opportunity to improve inpatient opioid prescribing practices which may reduce new prescriptions for continued outpatient therapy. Further work should focus on optimizing use of non-opioid analgesia, minimizing use of IV opioids and requiring prescribers to justify the indication for new opioid prescriptions upon hospital discharge.

Identifiants

pubmed: 33000671
doi: 10.1177/0897190020961290
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-183

Auteurs

Bryce Perkins (B)

Department of Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Banner University Medical Center, Tucson, AZ, USA.

Yvonne Huckleberry (Y)

Banner University Medical Center, Tucson, AZ, USA.
College of Pharmacy, University of Arizona, Tucson, AZ, USA.

Ivana Bogdanich (I)

Banner University Medical Center, Tucson, AZ, USA.
College of Pharmacy, University of Arizona, Tucson, AZ, USA.

Areerut Leelathanalerk (A)

Banner University Medical Center, Tucson, AZ, USA.
College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Mahasarakham University, Maha Sarakham, Thailand.

April Huckleberry (A)

Northern Arizona University, Flagstaff, AZ, USA.

Michaela Konecnik (M)

Banner University Medical Center, Tucson, AZ, USA.
College of Pharmacy, University of Arizona, Tucson, AZ, USA.

David C Miller (DC)

Department of Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Banner University Medical Center, Tucson, AZ, USA.

Morgan Bailey (M)

Department of Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Banner University Medical Center, Tucson, AZ, USA.

Christian Bime (C)

Department of Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
Banner University Medical Center, Tucson, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH